Beauty Health Company (SKIN) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

SKIN Stock Forecast

Beauty Health Company stock forecast is as follows: an average price target of $2.50 (represents a 79.86% upside from SKIN’s last price of $1.39) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

SKIN Price Target

The average price target for Beauty Health Company (SKIN) is $2.50 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $4.00 to $1.00. This represents a potential 79.86% upside from SKIN's last price of $1.39.

SKIN Analyst Ratings

Buy

According to 3 Wall Street analysts, Beauty Health Company's rating consensus is 'Buy'. The analyst rating breakdown for SKIN stock is 0 'Strong Buy' (0.00%), 1 'Buy' (33.33%), 1 'Hold' (33.33%), 1 'Sell' (33.33%), and 0 'Strong Sell' (0.00%).

Beauty Health Company Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 09, 2024	Korinne Wolfmeyer	Piper Sandler	$1.00	$1.14	-12.28%	-28.06%
May 10, 2024	Korinne Wolfmeyer	Piper Sandler	$2.50	$3.26	-23.31%	79.86%
Mar 13, 2024	Korinne Wolfmeyer	Piper Sandler	$3.00	$4.25	-29.41%	115.83%
Mar 13, 2024	Jonathan Block	Stifel Nicolaus	$4.00	$4.25	-5.88%	187.77%
Apr 28, 2022	-	Piper Sandler	$26.00	$13.14	97.86%	1770.50%

Row per page

Go to

The latest Beauty Health Company stock forecast, released on Aug 09, 2024 by Korinne Wolfmeyer from Piper Sandler, set a price target of $1.00, which represents a -12.28% decrease from the stock price at the time of the forecast ($1.14), and a -28.06% decrease from SKIN last price ($1.39).

Beauty Health Company Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	4
Avg Price Target	-	-	$2.63
Last Closing Price	$1.39	$1.39	$1.39
Upside/Downside	-100.00%	-100.00%	89.21%

In the current month, the average price target of Beauty Health Company stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Beauty Health Company's last price of $1.39. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 12, 2024	Cowen & Co.	Hold	Hold	Hold
Aug 09, 2024	Piper Sandler	Underweight	Underweight	Hold
Jul 11, 2024	Sandler O'Neill	Buy	Buy	Hold
Jul 11, 2024	Sandler O'Neil	Underperform	Underperform	Hold
May 13, 2024	Cowen & Co.	Hold	Hold	Hold
May 10, 2024	Piper Sandler	Underweight	Underweight	Hold
Mar 13, 2024	Piper Sandler	Hold	Hold	Hold
Mar 13, 2024	Piper Sandler	Underweight	Underweight	Hold
Nov 14, 2023	Raymond James	-	Underperform	Downgrade
Mar 01, 2023	Piper Sandler	Buy	Buy	Hold

Row per page

Go to

Beauty Health Company's last stock rating was published by Cowen & Co. on Aug 12, 2024. The company gave SKIN a "Hold" rating, the same as its previous rate.

Beauty Health Company Financial Forecast

Beauty Health Company Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$96.80M	$97.40M	$117.48M	$86.30M	$98.13M	$88.79M	$103.54M	$75.42M	$77.89M	$68.15M	$66.51M	-
Avg Forecast	$105.40M	$101.50M	$98.20M	$90.40M	$86.27M	$82.54M	$88.02M	$77.07M	$77.39M	$73.65M	$98.49M	$80.56M	$87.22M	$116.22M	$114.89M	$90.35M	$94.73M	$80.56M	$83.94M	$68.15M	$71.10M	$58.05M	$49.21M	$44.10M
High Forecast	$112.15M	$108.00M	$104.49M	$96.19M	$91.80M	$87.82M	$93.66M	$80.56M	$79.73M	$75.37M	$98.49M	$80.56M	$94.84M	$116.22M	$122.25M	$96.14M	$100.80M	$80.56M	$83.94M	$68.15M	$71.10M	$58.05M	$49.21M	$44.10M
Low Forecast	$98.35M	$94.71M	$91.63M	$84.35M	$80.50M	$77.02M	$82.14M	$70.57M	$75.59M	$71.92M	$98.49M	$80.56M	$83.89M	$116.22M	$107.21M	$84.31M	$88.39M	$80.56M	$83.94M	$68.15M	$71.10M	$58.05M	$49.21M	$44.10M
# Analysts	3	3	3	3	4	4	4	6	6	3	5	4	8	4	5	4	4	3	4	3	5	4	5	4
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.11%	0.84%	1.02%	0.96%	1.04%	1.10%	1.23%	1.11%	1.10%	1.17%	1.35%	-

Beauty Health Company's average Quarter revenue forecast for Mar 24 based on 4 analysts is $80.56M, with a low forecast of $80.56M, and a high forecast of $80.56M. SKIN's average Quarter revenue forecast represents a -16.78% decrease compared to the company's last Quarter revenue of $96.80M (Dec 23).

Beauty Health Company EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	3	3	3	3	4	4	4	6	6	3	5	4	8	4	5	4	4	3	4	3	5	4	5	4
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$-18.40M	$-70.50M	$-13.15M	$-12.50M	$530.00K	$-1.63M	$2.83M	$-7.85M	$-10.11M	$-211.20M	$-135.49M	$22.98M
Avg Forecast	$-16.36M	$-15.76M	$-15.24M	$-14.03M	$-13.39M	$-12.81M	$-13.66M	$-11.96M	$-12.01M	$-11.43M	$-15.29M	$-12.51M	$-13.54M	$-18.04M	$-17.84M	$-14.03M	$-14.71M	$-7.59M	$-7.91M	$-6.42M	$-6.70M	$-5.47M	$-325.18M	$-4.16M
High Forecast	$-15.27M	$-14.70M	$-14.22M	$-13.09M	$-12.50M	$-11.96M	$-12.75M	$-10.95M	$-11.73M	$-11.16M	$-15.29M	$-12.51M	$-13.02M	$-18.04M	$-16.64M	$-13.09M	$-13.72M	$-7.59M	$-7.91M	$-6.42M	$-6.70M	$-5.47M	$-260.15M	$-4.16M
Low Forecast	$-17.41M	$-16.77M	$-16.22M	$-14.93M	$-14.25M	$-13.63M	$-14.54M	$-12.51M	$-12.38M	$-11.70M	$-15.29M	$-12.51M	$-14.72M	$-18.04M	$-18.98M	$-14.92M	$-15.65M	$-7.59M	$-7.91M	$-6.42M	$-6.70M	$-5.47M	$-390.22M	$-4.16M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.36%	3.91%	0.74%	0.89%	-0.04%	0.21%	-0.36%	1.22%	1.51%	38.61%	0.42%	-5.53%

4 analysts predict SKIN's average Quarter EBITDA for Mar 23 to be $-14.03M, with a high of $-13.09M and a low of $-14.92M. This is -2746.37% lower than Beauty Health Company's previous annual EBITDA (Dec 22) of $530.00K.

Beauty Health Company Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	3	3	3	3	4	4	4	6	6	3	5	4	8	4	5	4	4	3	4	3	5	4	5	4
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$-9.40M	$-73.80M	$3.36M	$-22.20M	$3.81M	$131.00K	$7.93M	$32.51M	$-17.31M	$-215.15M	$-139.38M	$13.64M
Avg Forecast	$14.89M	$12.41M	$9.92M	$7.44M	$-4.76M	$-4.96M	$-4.55M	$-10.13M	$-13.65M	$-11.45M	$-1.87M	$-12.87M	$-9.15M	$9.19M	$5.80M	$-3.51M	$4.88M	$1.50M	$-903.23K	$457.86K	$-523.00K	$-1.96M	$-334.51M	$-3.55M
High Forecast	$16.13M	$13.44M	$10.75M	$8.06M	$-4.34M	$-4.53M	$-4.15M	$-7.09M	$-9.92M	$-10.45M	$-1.70M	$-11.75M	$-7.49M	$9.19M	$6.29M	$-3.21M	$5.29M	$1.50M	$-903.23K	$457.86K	$-523.00K	$-1.96M	$-267.61M	$-3.55M
Low Forecast	$13.59M	$11.33M	$9.06M	$6.80M	$-5.15M	$-5.38M	$-4.93M	$-13.17M	$-16.13M	$-12.40M	$-2.02M	$-13.94M	$-11.65M	$9.18M	$5.30M	$-3.81M	$4.46M	$1.50M	$-903.23K	$457.86K	$-523.00K	$-1.96M	$-401.41M	$-3.55M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.03%	-8.03%	0.58%	6.32%	0.78%	0.09%	-8.78%	71.00%	33.10%	109.84%	0.42%	-3.84%

Beauty Health Company's average Quarter net income forecast for Sep 23 is $9.19M, with a range of $9.18M to $9.19M. SKIN's average Quarter net income forecast represents a 173.08% increase compared to the company's last Quarter net income of $3.36M (Jun 23).

Beauty Health Company SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	3	3	3	3	4	4	4	6	6	3	5	4	8	4	5	4	4	3	4	3	5	4	5	4
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$61.00M	$67.70M	$78.14M	$69.10M	$67.49M	$63.55M	$72.47M	$62.67M	$62.10M	$49.65M	$70.62M	$17.70M
Avg Forecast	$72.51M	$69.83M	$67.56M	$62.19M	$59.35M	$56.78M	$60.56M	$53.02M	$53.24M	$50.67M	$67.76M	$55.42M	$60.01M	$79.96M	$79.04M	$62.16M	$65.17M	$55.13M	$57.45M	$46.64M	$48.66M	$39.73M	$33.68M	$30.18M
High Forecast	$77.16M	$74.30M	$71.89M	$66.18M	$63.15M	$60.42M	$64.44M	$55.42M	$54.85M	$51.85M	$67.76M	$55.42M	$65.25M	$79.96M	$84.11M	$66.14M	$69.35M	$55.13M	$57.45M	$46.64M	$48.66M	$39.73M	$33.68M	$30.18M
Low Forecast	$67.66M	$65.16M	$63.04M	$58.03M	$55.38M	$52.99M	$56.51M	$48.55M	$52.00M	$49.48M	$67.76M	$55.42M	$57.71M	$79.96M	$73.76M	$58.00M	$60.81M	$55.13M	$57.45M	$46.64M	$48.66M	$39.73M	$33.68M	$30.18M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.02%	0.85%	0.99%	1.11%	1.04%	1.15%	1.26%	1.34%	1.28%	1.25%	2.10%	0.59%

Beauty Health Company's average Quarter SG&A projection for Mar 24 is $55.42M, based on 4 Wall Street analysts, with a range of $55.42M to $55.42M. The forecast indicates a -9.14% fall compared to SKIN last annual SG&A of $61.00M (Dec 23).

Beauty Health Company EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	3	3	3	3	4	4	4	6	6	3	5	4	8	4	5	4	4	3	4	3	5	4	5	4
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$-0.07	$-0.56	$0.03	$-0.17	$0.03	-	$0.05	$0.22	$-0.12	$-1.63	$-1.52	$0.11
Avg Forecast	$0.12	$0.10	$0.08	$0.06	$-0.04	$-0.04	$-0.04	$-0.08	$-0.11	$-0.09	$-0.02	$-0.10	$-0.07	$0.07	$0.05	$-0.03	$0.04	$0.01	$-0.01	-	$-0.00	$-0.01	-	$-0.03
High Forecast	$0.13	$0.11	$0.09	$0.06	$-0.04	$-0.04	$-0.03	$-0.06	$-0.08	$-0.08	$-0.01	$-0.09	$-0.06	$0.07	$0.05	$-0.03	$0.04	$0.01	$-0.01	-	$-0.00	$-0.01	-	$-0.03
Low Forecast	$0.11	$0.09	$0.07	$0.05	$-0.04	$-0.04	$-0.04	$-0.11	$-0.13	$-0.10	$-0.02	$-0.11	$-0.09	$0.07	$0.04	$-0.03	$0.04	$0.01	$-0.01	-	$-0.00	$-0.01	-	$-0.03
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.99%	-7.56%	0.54%	6.00%	0.76%	0.09%	-7.86%	68.20%	32.56%	118.11%	-562.13%	-4.35%

According to 4 Wall Street analysts, Beauty Health Company's projected average Quarter EPS for Sep 23 is $0.07, with a low estimate of $0.07 and a high estimate of $0.07. This represents a 192.69% increase compared to SKIN previous annual EPS of $0.03 (Jun 23).

Beauty Health Company Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
FIGS	FIGS	$4.71	$13.00	176.01%	Hold
LPRO	Open Lending	$6.36	$15.00	135.85%	Hold
SKIN	Beauty Health Company	$1.39	$2.50	79.86%	Buy
YOU	Clear Secure	$25.89	$29.67	14.60%	Buy
GXO	GXO Logistics	$60.00	$64.14	6.90%	Buy
DOCS	Doximity	$48.00	$49.10	2.29%	Buy

SKIN Forecast FAQ

Is Beauty Health Company a good buy?

Yes, according to 3 Wall Street analysts, Beauty Health Company (SKIN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 33.33% of SKIN's total ratings.

What is SKIN's price target?

Beauty Health Company (SKIN) average price target is $2.5 with a range of $1 to $4, implying a 79.86% from its last price of $1.39. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Beauty Health Company stock go up soon?

According to Wall Street analysts' prediction for SKIN stock, the company can go up by 79.86% (from the last price of $1.39 to the average price target of $2.5), up by 187.77% based on the highest stock price target, and down by -28.06% based on the lowest stock price target.

Can Beauty Health Company stock reach $2?

SKIN's average twelve months analyst stock price target of $2.5 supports the claim that Beauty Health Company can reach $2 in the near future.

What are Beauty Health Company's analysts' financial forecasts?

Beauty Health Company's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $333.9M (high $353.84M, low $310.22M), average EBITDA is $-51.833M (high $-48.157M, low $-54.928M), average net income is $-24.398M (high $-20.118M, low $-28.626M), average SG&A $229.72M (high $243.44M, low $213.43M), and average EPS is $-0.197 (high $-0.162, low $-0.231). SKIN's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $395.5M (high $420.83M, low $369.05M), average EBITDA is $-61.395M (high $-57.289M, low $-65.327M), average net income is $44.66M (high $48.38M, low $40.78M), average SG&A $272.1M (high $289.52M, low $253.9M), and average EPS is $0.36 (high $0.39, low $0.329).

Did the SKIN's actual financial results beat the analysts' financial forecasts?

Based on Beauty Health Company's last annual report (Dec 2023), the company's revenue was $397.99M, which missed the average analysts forecast of $408.69M by -2.62%. Apple's EBITDA was $-131M, beating the average prediction of $-63.442M by 106.36%. The company's net income was $-100M, missing the average estimation of $2.33M by -4405.21%. Apple's SG&A was $275.93M, missing the average forecast of $281.17M by -1.87%. Lastly, the company's EPS was $-0.76, missing the average prediction of $0.0187 by -4154.41%. In terms of the last quarterly report (Dec 2023), Beauty Health Company's revenue was $96.8M, beating the average analysts' forecast of $87.22M by 10.98%. The company's EBITDA was $-18.4M, beating the average prediction of $-13.54M by 35.89%. Beauty Health Company's net income was $-9.4M, beating the average estimation of $-9.151M by 2.72%. The company's SG&A was $61M, beating the average forecast of $60.01M by 1.65%. Lastly, the company's EPS was $-0.073, missing the average prediction of $-0.0738 by -1.04%